Highly water-soluble, pH sensitive and biocompatible PAMAM ‘dendrizyme’ to maintain catalytic activity in complex medium

Development of an Ultrasmall and Biocompatible Platinum Nanozyme Encapsulated by Zwitterionic Dendrimer for Highly Sensitive Detection of Glucose

Many kinds of noble metal nanoparticles can mimic the peroxidase-like function of horseradish peroxidase, which results in their wide applications in bio-related detection and drug delivery. However, those metal nanoparticles usually have low stability and reduced catalytic activity in biological complex medium. Herein, a zwitterionic peroxidase-like enzyme has been developed, which has high stability in fibrinogen solutions and high sensitivity for glucose detection. Maleic anhydride, cysteamine, and zwitterionic peptide EKEKC (EK-5) were used to modify generation 5 poly(amido amine) dendrimers (G5 PAMAM) to prepare zwitterionic dendrimer G5MEKnC with nonfouling properties. Finally, the G5MEKnC-encapsulated platinum nanoparticles (Pt_n-G5MEK50C) were prepared by entrapping the platinum nanoparticles (1.40 nm) in the catalytic centers in the interior of G5MEK50C. Pt₅₅-G5MEK50C showed high stability in the buffer solution and the fibrinogen solution within 4 days. They also displayed high biocompatibility toward HeLa cells based on cytotoxicity results and morphological observations. Furthermore, the catalytic oxidation of 3,3',5,5'-tetramethylbenzidine with H₂O₂ by Pt₅₅-G5MEK50C followed the Michaelis-Menten equation, which confirmed their peroxidase-like properties. The catalytic mechanism was due to the generation of ^•OH from H₂O₂. More importantly, the peroxidase-like ability of Pt₅₅-G5MEK50C was successfully used to establish a method for the determination of glucose concentration with a broad linear range of 1-2000 μM and a low detection limit of 0.1 μM. This method was highly accurate for the determination of glucose concentration in plasma. The zwitterionic dendrimer template enhanced the properties of Pt₅₅-G5MEK50C. Taken together, a new kind of biocompatible nanozyme has been developed and successfully used for the sensitive detection of glucose in bio-related medium.

Toxicity And Surface Modification Of Dendrimers: A Critical Review

As compared to other nano polymers, dendrimers have novel three dimensional, synthetic hyperbranched, nano-polymeric structures. The characteristic of these supramolecular dendritic structures has a high degree of significant surface as well as core functionality in the transportation of drugs for targeted therapy, specifically in host-guest response, gene transfer therapy and imaging of biological systems. However, there are conflicting shreds of evidence regarding biological safety and dendrimers toxicity due to their positive charge at the surface. It includes cytotoxicity, hemolytic toxicity, haematological toxicity, immunogenicity and in vivo toxicity. Therefore to resolve these problems surface modification of the dendrimer group is one of the methods. From that point, this review involves different strategies which reduce the toxicity and improve the biocompatibility of different types of dendrimers. From that viewpoint, we broaden the structural and safe characteristics of the dendrimers in the biomedical and pharmaceutical fields.

Highly biocompatible zwitterionic dendrimer-encapsulated platinum nanoparticles for sensitive detection of glucose in complex medium

The sensitive detection of glucose using zwitterionic dendrimer-encapsulated platinum nanoparticles was not affected by proteins.

Biocompatible bovine serum albumin stabilized platinum nanoparticles for the oxidation of morin

Bovine serum albumin stabilized platinum nanoparticles promoted the formation of ˙OH from H₂O₂to catalyze the oxidation of morin.

Highly biocompatible jujube polysaccharide-stabilized palladium nanoparticles with excellent catalytic performance

Jujube polysaccharide-stabilized palladium nanoparticles provide active sites for efficient catalysis of 4-nitrophenol to 4-aminophenol.

Enhanced glucose detection using dendrimer encapsulated gold nanoparticles benefiting from their zwitterionic surface

The application of ultrasmall gold nanoparticles as enzyme mimics has been drawing great attention. Herein, we developed zwitterionic dendrimer encapsulated gold nanoparticles (Au-G5MC NPs) for highly sensitive and simple colorimetric detection of glucose. Au-G5MC NPs showed peroxidase-like property, which could efficiently catalyze oxidation of 3,3',5,5'-tetramethylbenzidine (TMB) in the presence of H₂O₂, producing a blue color product (oxTMB). This peroxidase-like reaction follows a typical Michaelis-Menten kinetics. The K_m towards TMB exhibited a lower value (0.194 mM) than that of horseradish peroxidase (HRP, 0.434 mM). Furthermore, the peroxidase-like properties of Au-G5MC NPs enable colorimetric detection of the concentration of glucose with high selectivity. The linear concentration range of this method was from 14 μM to 166 μM with the detection limit down to 3.8 μM. More importantly, the detection was not interfered by proteins due to the single zwitterionic layer on the Au-G5MC NPs surface. These excellent properties are attributed to the ultrasmall size of gold nanoparticles and high stability of Au-G5MC NPs in complex medium. This catalytic system might have great potential applications for glucose detection in medical diagnostics and biochemistry in the future.

Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer

Although novel molecular targeted drugs have been recognized as an effective therapy for non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) activating mutations, their efficacy fails to meet the expectation due to the acquired resistance in tumors. Up-regulation of the anti-apoptotic protein Survivin was shown to contribute to the resistance to EGFR tyrosine kinase inhibitors (TKI) in EGFR mutation-positive NSCLC. However, the unorganized tumor blood vessels impeded drug penetration into tumor tissue. The resulting insufficient intracellular drug/gene delivery in drug-resistant cancer cells remarkably weakened the drug efficacy in NSCLC. In this work, a multi-functional drug delivery system AP/ES was developed by using anti-EGFR aptamer (Apt)-modified polyamidoamine to co-deliver erlotinib and Survivin-shRNA. Chloroquine (CQ) was used in combination with AP/ES to normalize tumor vessels for sufficient drug/gene delivery to overcome drug resistance in NSCLC cells. The obtained AP/ES possessed desired physicochemical properties, good biostability, controlled drug release profiles, and strong selectivity to EGFR-mutated NSCLC mediated by Apt. CQ not only enhanced endosomal escape ability of AP/ES for efficient gene transfection to inhibit Survivin, but also showed strong vessel-normalization ability to improve tumor microcirculation, which further promoted drug delivery and enhanced drug efficacy in erlotinib-resistant NSCLC cells. Our innovative gene/drug co-delivery system in combination with CQ showed a promising outcome in fighting against erlotinib resistance both in vitro and in vivo. This work indicates that normalization of tumor vessels could help intracellular erlotinib/Survivin-shRNA delivery and the down-regulation of Survivin could act synergistically with erlotinib for reversal of erlotinib resistance in EGFR mutation-positive NSCLC.

STATEMENT OF SIGNIFICANCE

NSCLC patients who benefited from EGFR-TKIs inevitably developed acquired resistance. Previous research focused on synthesis of new generation of molecular targeted drugs that could irreversibly inhibit EGFR with a particular gene mutation to overcome drug resistance. However, they failed to inhibit EGFR with other gene mutations. Activation of bypass signaling pathway and the changes of tumor microenvironment are identified as two of the mechanisms of acquired resistance to EGFR-TKIs. We therefore constructed multifunctional gene/drug co-delivery nanocomplexes AP/ES co-formulated with chloroquine that could target the both two mechanisms. We found that chloroquine not only enhanced endosomal escape ability of AP/ES for efficient gene transfection to inhibit Survivin, but also showed strong vessel-normalization ability to improve tumor microcirculation, which further promoted drug delivery into tumor tissue and enhanced drug efficacy in erlotinib-resistant NSCLC.

Highly stable and biocompatible zwitterionic dendrimer-encapsulated palladium nanoparticles that maintain their catalytic activity in bacterial solution

This study offers a method for constructing an artificial enzyme (Pd_n-G5MC), which maintains its catalytic efficiency in bacterial solution.

Highly stable and biocompatible dendrimer-encapsulated gold nanoparticle catalysts for the reduction of 4-nitrophenol

The enhanced properties of dendrimer-encapsulated gold nanoparticles were attributed to the single zwitterionic layer on the new dendrimer template.